Project Details
Description
Comprehensive study on the portein expression of RANKL and associated proten (RNK and OPG) in benign breast and malignant breast tissues among menstrual phases will provide us better understanding of the role of progesterone and RANKL-mediated paracrine pathway on breast cancer risk to seek new prevention approach.
Status | Finished |
---|---|
Effective start/end date | 12/3/12 → 12/3/14 |
Funding
- Amgen, Inc. (-)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.